Oral Semaglutide Oral semaglutide was the first GLP-1 medicine available as a tablet
No, this doesnt mean restricting yourself so that youre only eating five specific foods a day or that you can never have your favorite dishes again
Insights into managing obesity-related comorbidities
The 2020 fraud conviction and sentencing In November 2020, Mihir Taneja, the former CEO of GeoPharma, pleaded guilty to "introduction of misbranded drugs into interstate commerce with the intent to defraud and mislead." The Department of Justice characterized the scheme as part of a "Nationwide Telemedicine Pharmacy Health Care Fraud Conspiracy." The specifics of the conviction involved paying kickbacks to physicians and repackaging over-the-counter medicines and vitamins as prescription-only drugs to inflate pricing
OASIS 4 Key Results 6% mean weight loss at 64 weeks among participants who remained fully adherent to treatment, compared to 2.7% for placebo a difference of nearly 14 percentage points 6% mean weight loss at 64 weeks when analyzed across all randomized participants regardless of whether they stayed on treatment, versus 2.4% for placebo One in three fully adherent participants achieved weight loss of 20% or more, compared to fewer than 3% in the placebo group Significant improvements in cardiometabolic risk factors including blood pressure, cholesterol levels, and glycemic markers were observed across the treatment group These results represent a landmark in pharmacology
